1 day ago · The Food and Drug Administration ( FDA ), the US regulating authority in the sphere of medical devices, has published a discussion paper dedicated to the proposed regulatory framework for modifications to the software as a medical device (SaMD) based on the artificial intelligence/machine learning technologies.
5/29/2019 · The FDA recently issued a discussion paper and request for feedback titled, “Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning [ AI/ML ]-Based Software as a Medical Device.” The challenge artificial intelligence ( AI ) and machine learning ( ML ) present to FDA device regulation is straightforward: the FDA must approve or clear devices as safe.
4/10/2019 · On April 2, 2019, FDA released a discussion paper entitled “Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning ( AI/ML )-Based Software as a Medical Device (SaMD)” (the “ AI Framework”). The AI Framework is the Agency’s first policy document describing a potential regulatory approach for medical devices that use artificial intelligence (“ AI ”) and …
On April 2, 2019, the FDA published a discussion paper , “Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning ( AI/ML )-Based Software as a Medical Device (SaMD) – Discussion Paper and Request for Feedback” that outlines the FDA ’s foundation for a possible approach to premarket review for AI software …
Artificial Intelligence and Machine Learning in Software …
Artificial Intelligence and Machine Learning in Software …
Artificial Intelligence and Machine Learning in Software …
